About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Your Own Cells may Treat Parkinson's Disease

by Dr. Enozia Vakil on September 27, 2013 at 6:35 PM
 Your Own Cells may Treat Parkinson's Disease

Induced pluripotent stem cells (iPSCs) extracted from the patient itself may be extremely helpful in treating many disease. However, studies in rodents have suggested that the body may mount an immune response and destroy cells derived from iPSCs. New research in monkeys refutes these findings, suggesting that in primates like us, such cells will not be rejected by the immune system. In the paper, publishing September 26 in the ISSCR's journal Stem Cell Reports, published by Cell Press, iPSCs from nonhuman primates successfully developed into the neurons depleted by Parkinson's disease while eliciting only a minimal immune response. The cells therefore could hold promise for successful transplantation in humans.

iPSCs are cells that have been genetically reprogrammed to an embryonic stem-cell-like state, meaning that they can differentiate into virtually any of the body's different cell types. iPSCs directed to differentiate into specific cell types offer the possibility of a renewable source of replacement cells and tissues to treat ailments, including Parkinson's disease, spinal cord injury, heart disease, diabetes, and arthritis.

Advertisement

Studies in rodents have suggested that iPSC-derived cells used for transplantation may be rejected by the body's immune system. To test this in an animal that is more closely related to humans, investigators in Japan directed iPSCs taken from a monkey to develop into certain neurons that are depleted in Parkinson's disease patients. When they were injected into the same monkey's brain (called an autologous transplantation), the neurons elicited only a minimal immune response. In contrast, injections of the cells into immunologically unmatched recipients (called an allogeneic transplantation) caused the body to mount a stronger immune response.

"These findings give a rationale to start autologous transplantation—at least of neural cells—in clinical situations," says senior author Dr. Jun Takahashi, of the Kyoto University's Center for iPS Cell Research and Application. The team's work also suggests that transplantation of such neurons into immunologically matched recipients may be possible with minimal use of immunosuppressive drugs.



Source: Eurekalert
Font : A-A+

Advertisement

Advertisement
Advertisement

Latest Genetics & Stem Cells News

Genetic Insights Into Androgenetic Alopecia's
Innovative discoveries in male hair loss research uncover uncommon genetic variants tied to it.
Uncovering Genetic Harmony for Safer Hearts
Researchers achieved a significant milestone in uncovering the genetic basis of dilated cardiomyopathy in Dobermanns.
Gene Therapy Breaks Up New Dawn for Beta Thalassemia
Groundbreaking gene therapy for genetic beta thalassemia is now accessible as a treatment to a patient post-FDA approval.
Scientists Uncover Stem Cells in the Thymus for the First Time
Thymic stem cells actively participate in their environment by generating extracellular matrix proteins, essentially forming their own support system.
First Allogenic Stem Cell Transplant
Scientists aspire to utilize stem cell transplantation for pediatric patients grappling with blood-related conditions like aplastic anemia, and thalassemia.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
MediBotMediBot
Greetings! How can I assist you?MediBot
×

Your Own Cells may Treat Parkinson's Disease Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests